Eli Lilly and Company (NYSE:LLY) shares are trading lower Friday, among other GLP-1 drug manufacturers, following President Donald Trump‘s comments that fat-loss drugs will be a lot lower in price.
What To Know: In a Thursday press conference, Trump told reporters that popular fat-loss drugs like Eli Lilly's Mounjaro and Novo Nordisk's (NYSE:NVO) Ozempic will see price reductions. The comments sent shares of GLP-1 drugmakers lower in after-hours trading on Thursday.
GLP-1 medications are used to treat Type 2 diabetes and obesity. Tirzepatide is the active ingredient in Eli Lilly's Mounjaro and Zepbound, while semaglutide is the active ingredient in Novo Nordisk's Ozempic and Wegovy.
How To Buy Eli Lilly Stock
By now you're likely curious about how to participate in the market for Eli Lilly – be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy “fractional shares,” which allows you to own portions of stock without buying an entire share.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to “go short” a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.
See Also: Marsh & McLennan Analysts Slash Their Forecasts Following Q3 Earnings
LLY Price Action: At the time of writing, Eli Lilly shares are trading 2.42% lower at $799.53, according to data from Benzinga Pro.
Image via Shutterstock
